Purpose. A possible role for fondaparinux as a bridging agent in the perioperative setting is explored. Summary. Anticoagulation guidelines provide minimal direction on the perioperative use of ...

Researchers have found in a cohort study that patients with atrial fibrillation (AF) receiving a factor Xa inhibitor and ...

Aplagon, a clinical stage biopharmaceutical company developing a first-in-class therapeutic for thrombo-inflammatory diseases, known as APAC, a heparin proteoglycan mimetic with antiplatelet and ...

Researchers have found in a new research that among patients with atrial fibrillation who are at moderate-to-high risk for stroke, administration of abelacimab at doses of 90 mg or 150 mg led to ...

In observational studies involving warfarin-treated patients who received LMWH bridging, rates of major bleeding appeared lower if patients do not receive bridging.22–24 The HASBLED (Hypertension, ...

In Kashmir, leech therapy is experiencing a resurgence as a trusted alternative to modern medicine. Practitioners like Mohd ...

No anticoagulation or antiplatelet was administered to the ... remodeling balloons or temporary neck-bridging devices, a novel device class consisting of self-expandable nickel-titanium mesh ...

Unfortunately, this also means you are more likely to have shearing of the bridging veins, leading to a subdural hematoma. Even a stumble could potentially cause a bleed. Patients on Warfarin ...

Patients on oral anticoagulants or antiplatelet agents showed no meaningful difference in detection rates. Oral anticoagulant or antiplatelet medication use had no substantial effect on the ...